6 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
DVT = deep vein ... thrombosis; PE = ... pulmonary embolism ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... Embolism • Provoked ... #PE #Pulmonary # ... #hematology #VTE
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
Recurrent / Breakthrough ... #Recurrent #DVT ... #VTE #anticoagulation ... #hematology #differential ... #algorithm
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... and Management Algorithm ... #Thrombosis #Algorithm ... #Extension #VTE ... #DVT #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... or PE in cancer ... single subsegmental PE ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Isolated distal DVT ... Unprovoked proximal DVT ... or PE - High ... therapy - Second VTE ... #management #hematology